Last $32.27 USD
Change Today -0.31 / -0.95%
Volume 371.2K
ACOR On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

acorda therapeutics inc (ACOR) Snapshot

Open
$32.55
Previous Close
$32.58
Day High
$33.13
Day Low
$32.08
52 Week High
03/19/14 - $39.95
52 Week Low
01/7/14 - $27.51
Market Cap
1.3B
Average Volume 10 Days
578.0K
EPS TTM
$0.46
Shares Outstanding
41.7M
EX-Date
--
P/E TM
69.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for ACORDA THERAPEUTICS INC (ACOR)

acorda therapeutics inc (ACOR) Related Businessweek News

No Related Businessweek News Found

acorda therapeutics inc (ACOR) Details

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. The company’s products include Ampyra (dalfampridine), a potassium channel blocker to improve walking in patients with MS; Zanaflex Capsules and Zanaflex tablets, a short-acting drug for the management of spasticity, a symptom of central nervous system disorders; and Qutenza, a dermal patch for the management of neuropathic pain. It is also involved in developing Diazapam Nasal Spray for the treatment of cluster/acute repetitive seizures; Dalfampridine that is in Phase III clinical development program preparations for post-stroke deficits; NP-1998, a topical solution that is in phase III clinical trail for the treatment of neuropathic pain; AC105, which is in Phase II clinical trials for the treatment of SCI; Neuregulin Program that has completed Phase 1 clinical trial for the treatment of heart failure; Remyelinating Antibodies Program, which is in Phase 1 clinical trial for the treatment of MS; and Chondroitinase Program that is in research for the treatment of injuries to the brain and spinal cord, as well as other neurotraumatic indications. The company was founded in 1995 and is headquartered in Ardsley, New York.

421 Employees
Last Reported Date: 03/3/14
Founded in 1995

acorda therapeutics inc (ACOR) Top Compensated Officers

Founder, Chief Executive Officer, President a...
Total Annual Compensation: $720.8K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $193.9K
Chief of Business Operations
Total Annual Compensation: $312.7K
General Counsel, Corporate Secretary and Pres...
Total Annual Compensation: $517.7K
Chief Medical Officer
Total Annual Compensation: $418.5K
Compensation as of Fiscal Year 2013.

acorda therapeutics inc (ACOR) Key Developments

Acorda Therapeutics, Inc., Civitas Therapeutics, Inc. - M&A Call

To discuss entry of Acorda Therapeutics into an agreement to acquire Civitas Therapeutics

Acorda Therapeutics, Inc. Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-11-2014 09:30 AM

Acorda Therapeutics, Inc. Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-11-2014 09:30 AM. Venue: The Encore at Wynn Las Vegas, 3121 Las Vegas Blvd. South, Las Vegas, NV 89109, United States. Speakers: Michael W. Rogers, Chief Financial Officer and Principal Accounting Officer.

Acorda Therapeutics, Inc. Presents at Citi's 9th Annual Biotech Conference, Sep-03-2014

Acorda Therapeutics, Inc. Presents at Citi's 9th Annual Biotech Conference, Sep-03-2014 . Venue: The Mandarin Oriental Boston, 776 Boylston Street, Boston, MA 02119, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $32.27 USD -0.31

ACOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biogen Idec Inc $309.07 USD -17.70
Durect Corp $1.42 USD +0.07
Novartis AG SFr.84.65 CHF +1.10
Teva Pharmaceutical Industries Ltd $53.21 USD -0.05
View Industry Companies
 

Industry Analysis

ACOR

Industry Average

Valuation ACOR Industry Range
Price/Earnings 72.1x
Price/Sales 3.8x
Price/Book 2.7x
Price/Cash Flow 71.4x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit www.acorda.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.